Niagen Bioscience, Inc. — Director's Dealing 2013

Mar 15, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2013-03-13

Reporting Person: Brauser Michael (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-13	Common Stock	X	833333	$0.21	Acquired	4394926	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-13	Warrant to Purchase Common Stock	$0.21	X	833333	Disposed	2013-05-20	Common Stock (833333)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1860712	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant to Purchase Common Stock	$0.21	2013-05-20	Common Stock (100000)	100000	Direct
Warrants to Purchase Common Stock	$0.21	2013-05-20	Common Stock (1860712)	1860712	Indirect

Footnotes

F1: Indirect beneficial ownership includes: (i) 314,285 Shares held by Grander Holdings, Inc. 401K Profit Sharing Plan of which the Reporting Person is a trustee; (ii) 342,857 Shares held by the Brauser 2010 GRAT of which the Reporting Person is a trustee; (iii) 846,428 Shares held by BMB Holdings, LLLP of which the Reporting Person is the manager of its general partner; and (iv) 357,142 Shares held by Betsy Brauser Third Amended Trust Agreement beneficially owned by the Reporting Person's spouse which are disclaimed by him.

F2: Indirect beneficial ownership includes: (i) 314,285 Warrants held by Grander Holdings, Inc. 401K Profit Sharing Plan of which the Reporting Person is a trustee; (ii) 342,857 Warrants held by the Brauser 2010 GRAT of which the Reporting Person is a trustee; (iii) 846,428 Warrants held by BMB Holdings, LLLP of which the Reporting Person is the manager of its general partner; and (iv) 357,142 Warrants held by Betsy Brauser Third Amended Trust Agreement beneficially owned by the Reporting Person's spouse which are disclaimed by him.